Improvement of self-administration experience with a new injection device: Real-life experience with risankizumab in patients with psoriasis.
Alexandra Maria Giovanna BrunassoIlaria SalviStefania SorbaraAndrea MuracchioliElena De ColManuela BaldariAurora ParodiEmanuele CozzaniMartina BurlandoPublished in: Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) (2024)
User-friendly devices, such as prefilled pens, and a lower number of injections improved patient satisfaction in a group of patients with psoriasis on treatment with biologic drugs. We believe that treatment adherence could be positively influenced by such changes in the way of administration of a biologic treatment.